Corza Medical GmbH
🇨ðŸ‡Switzerland
- Country
- 🇨ðŸ‡Switzerland
- Ownership
- Private
- Established
- 2021-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- https://corza.com
A Phase III Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery
Phase 3
Not yet recruiting
- Conditions
- Hemorrhage
- Interventions
- Biological: Surgicel Original
- First Posted Date
- 2024-10-30
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- Corza Medical GmbH
- Target Recruit Count
- 116
- Registration Number
- NCT06664775
© Copyright 2025. All Rights Reserved by MedPath